HLA-DRB1 gene transcripts in rheumatoid arthritis

Area of Science:

• Immunogenetics
• Molecular Biology
• Rheumatology

Background:

• Rheumatoid arthritis (RA) susceptibility is strongly associated with specific Human Leukocyte Antigen (HLA)-DRB1 alleles.
• The precise molecular mechanisms underlying this HLA-DRB1 association with RA remain largely unknown.
• Variations in HLA-DRB1 gene expression levels in immune cells could play a role in disease susceptibility.

Purpose of the Study:

• To investigate the allelic expression levels of HLA-DRB1 in B cells from healthy individuals and RA patients.
• To determine if differential HLA-DRB1 gene expression correlates with RA risk alleles and disease status.
• To explore potential molecular mechanisms linking HLA-DRB1 genotype to RA pathogenesis.

Main Methods:

• Collected peripheral blood B cells from healthy controls and RA patients.
• Quantified allelic HLA-DRB1 transcript levels using a competitive Polymerase Chain Reaction (PCR) approach.
• Analyzed the correlation between HLA-DRB1 transcript levels, HLA-DRB1 genotype, and clinical/biological features.

Main Results:

• HLA-DRB1 gene expression levels were significantly altered in RA patients compared to controls.
• Patients with a double dose of RA-associated HLA-DRB1 alleles exhibited upregulated DRB1 transcript levels.
• Individuals with single or no risk alleles showed low DRB1 transcript levels, irrespective of clinical, biological, or therapeutic factors.

Conclusions:

• Differential regulation of HLA-DRB1 gene expression in B cells is observed in RA patients.
• Upregulated DRB1 expression in patients with risk alleles may contribute to altered T cell responses.
• This altered gene expression pattern represents a potential molecular mechanism underlying the HLA-DRB1 association with rheumatoid arthritis.